Navigation Links
Lab-on-chip testing for 'bird flu' developed by Singapore scientists
Date:9/24/2007

SINGAPORE, Sept. 23, 2007 - Researchers at the Institute of Bioengineering and Nanotechnology (IBN), Institute of Molecular and Cell Biology (IMCB) and Genome Institute of Singapore (GIS) have successfully developed a miniaturized device that can be used to detect the highly pathogenic avian flu (H5N1) virus.

If successfully commercialized, this device could be deployed in affected regions for pre-emptive surveillance of nascent avian flu epidemic.

According to project leader and lead author of the Nature Medicine publication, IBN Research Scientist Dr Juergen Pipper, "With our device, medical or humanitarian aid workers would be able to detect the presence of the H5N1 virus directly from throat swab samples on-site in less than half an hour."

With early warning, a potential avian flu epidemic can be averted. Avian influenza is now entrenched in Asia, with sporadic human infections resulting from either direct contact with infected birds or limited human-to-human transmission. Globalization and seasonal avian migration patterns have resulted in the disease spreading rapidly to other parts of the world.

The device comprises a unique platform developed by IBN that uses magnetic force to manipulate individual droplets containing silica-coated magnetic particles.

"The novelty of our method lies in the way that the droplet itself becomes a pump, valve, mixer, solid-phase extractor and real-time thermocycler. Complex biochemical tasks can thus be processed in a fashion similar to that of a traditional biological laboratory on a miniature scale," explained Dr Pipper.

The all-in-one droplet-based device is superior to commercially available solutions as it integrates the entire workflow of viral RNA isolation, purification, preconcentration, and detection.

Tests have shown that IBN's platform is as sensitive as, and around 10 times faster than available tests, yet it could potentially be 40 to 100 times cheaper. IMCB co-author, Masafumi Inoue, is also the leading inventor for the Avian Flu (H5N1) detection kit that is currently being used in hospitals.

He adds that, "We had been developing the H5N1 detection kits and thus accumulated technical knowledge like primers and cycling conditions for the PCR assay. We are very pleased to see that these techniques were an advantage in improving the development of the new platform."

GIS co-author, Dr Lisa Ng, who was a co-inventor in another Avian Flu (H5N1) detection kit using GIS' proprietary nucleic acid diagnostic primers, played a role in the initial designs of the PCR and Primers assays in this project.

"We have a long journey ahead of us in our battle against infectious diseases, and the current avian influenza outbreaks caused by influenza A (H5N1) underscore the importance of improving our preparedness for the next emerging or re-emerging infectious agent." said Dr Ng.

Asked about the collaborations with other institutes, Professor Jackie Ying, Executive Director of IBN affirmed that "IBN is delighted that Dr Juergen Pipper has initiated this multidisciplinary collaboration with our A*STAR sister institutes at the Biopolis. We are also pleased that two of our Youth Research Program attachment students have made substantial contribution to this project and are co-authors to this publication."

The unique lap-on-a-chip system developed by IBN can also be adapted for other infectious diseases such as SARS, HIV and hepatitis B, by extracting nucleic acids from other body fluids such as blood, urine or saliva.

"An increasing number of magnetic particle-based biochemical kits are commercially available to process cells, RNA, DNA and proteins. We envision that our droplet-based system will be an attractive diagnostic platform, especially for decentralized environmental, biological or medical testing," said Dr Pipper.


'/>"/>

Contact: Cathy Yarbrough
sciencematter@yahoo.com
858-243-1814
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert

Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
3. Diabetic testing gets easier
4. FDA changes rules on testing drugs for children
5. Gene testing kit specific for Doctors
6. Testing for blood sugar levels made easier
7. H.Pylori testing recommended in patients with peptic ulcer
8. DNA Testing For More Accurate Results
9. SARS vaccine shows promise in Animal Testing
10. Testing Of Saliva May Predict Dental Caries
11. Diagnosing Sleep Apnea By Overnight Sleep Testing Method
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Ill. , June 23, 2016  In a startling report ... are failing their residents by lacking a comprehensive, proven plan to ... a definitive ranking of how states are tackling the worst ... to only four states – Kentucky , ... Vermont . Of the 28 failing states, three ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
Breaking Medicine Technology: